Cryo-Cell International is a medical - care facilities company in the healthcare sector trading on AMEX, led by CEO David I. Portnoy, with a market cap of $65.1M.
Upcoming earnings announcement for Cryo-Cell International
Past 12 earnings reports for Cryo-Cell International
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Q4 2025 | -$0.13Est: -$0.09 | -44.4% | $7.8MEst: $7.7M | +1.9% | |
| Oct 15, 2025 | Q3 2025 | $0.09Est: -$0.03 | +400.0% | $7.8MEst: $8.0M | -1.9% | |
| Jul 15, 2025 | Q2 2025 | $0.04Est: -$0.04 | +200.0% | $7.9MEst: $8.0M | -1.4% | |
| Apr 15, 2025 | Q1 2025 | $0.03Est: $0.01 | +200.0% | $8.0MEst: $7.9M | +1.1% | |
| Feb 28, 2025 | Q4 2024 | -$0.22Est: $0.03 | -833.3% | $8.0MEst: $7.9M | +1.1% | |
| Oct 15, 2024 | Q3 2024 | $0.13Est: $0.02 | +550.0% | $8.1MEst: $8.0M | +1.0% | |
| Jul 15, 2024 | Q2 2024 | $0.08Est: $0.04 | +100.0% | $8.0MEst: $8.0M | +1.2% | |
| Apr 15, 2024 | Q1 2024 | $0.07Est: -$0.02 | +450.0% | $7.9MEst: $7.9M | -1.0% | |
| Feb 28, 2024 | Q4 2023 | $0.23Est: -$0.07 | +428.6% | $7.9MEst: $7.9M | -0.4% | |
| Oct 12, 2023 | Q3 2023 | $0.08Est: -$0.06 | +233.3% | $7.9MEst: $7.8M | +1.3% | — |
| Jul 14, 2023 | Q2 2023 | $0.03Est: -$0.08 | +137.5% | $7.8MEst: $7.8M | 0.0% | — |
| Apr 21, 2023 | Q1 2023 | $0.09Est: -$0.04 | +325.0% | $7.8MEst: $7.4M | +5.5% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.